ANDREA VACHA: Open Payments
NPI 1922507086 · FREMONT, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 59 payments from 20 companies in 2025. Trend: 2023 $657 · 2024 $526 · 2025 $980
Food & beverage: $980
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $178 |
| Lilly USA, LLC | 11 | $133 |
| Amgen Inc. | 6 | $97 |
| Novo Nordisk Inc | 6 | $95 |
| Otsuka America Pharmaceutical, Inc. | 5 | $83 |
| ABBVIE INC. | 5 | $78 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $58 |
| PFIZER INC. | 3 | $53 |
| Astellas Pharma US Inc | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: EVENITY, REXULTI, Wegovy, MOUNJARO, AIRSUPRA, VRAYLAR, JARDIANCE, KISUNLA.
Industry payments across NE — which companies pay providers there.
